Additionally, Greer et al. demonstrated that ClpP modulators impair breast cancer stem cell (CSC) function by targeting glutamine-proline and one-carbon metabolism, resulting in NAD(P)+ depletion and oxidative stress. This evidence concerns the gene CLPP and breast carcinoma.